Emergency contraception OTC
Executive Summary
Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by FDA's Nonprescription Drugs and Reproductive Health Drugs Advisory Committees in mid-December. Both committees are tentatively scheduled to meet Dec. 16. A switch application for Plan B was filed April 21...
You may also be interested in...
Barr’s women’s health strategy goes to Plan B
Barr acquires Women's Capital Corporation's emergency oral contraceptive Plan B. The company will continue to pursue over-the-counter status for Plan B; the emergency contraceptive is expected to be considered by FDA's Nonprescription Drugs & Reproductive Health Drugs Advisory Committees in mid-December (1"The Pink Sheet" Sept. 29, 2003, In Brief). Barr will also acquire "certain other assets and liabilities" from WCC...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.